Oyster Point Pharma, Inc.·4

Aug 11, 4:03 PM ET

Snisarenko John 4

4 · Oyster Point Pharma, Inc. · Filed Aug 11, 2020

Insider Transaction Report

Form 4
Period: 2020-08-10
Snisarenko John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2020-08-10$25.97/sh+4,000$103,8807,000 total

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_932692

    POA DOCUMENT